XML 13 R4.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statements of Income - USD ($)
3 Months Ended 9 Months Ended
Dec. 29, 2019
Dec. 30, 2018
Dec. 29, 2019
Dec. 30, 2018
Consolidated Statements of Income        
Revenues $ 139,578,200 $ 152,294,500 $ 412,118,400 $ 461,850,000
Cost of goods sold 116,503,900 121,295,800 337,461,300 368,758,500
Gross profit 23,074,300 30,998,700 74,657,100 93,091,500
Selling, general and administrative expenses 26,479,100 27,494,800 80,320,800 85,933,400
Goodwill impairment 2,569,100   2,569,100  
Restructuring charge     488,000  
(Loss) income from operations (5,973,900) 3,503,900 (8,720,800) 7,158,100
Interest expense, net 367,900 247,900 911,700 667,100
(Loss) income before provision for (benefit from) income taxes (6,341,800) 3,256,000 (9,632,500) 6,491,000
(Benefit from ) provision for income taxes (1,320,400) 551,400 (2,140,300) 1,437,200
Net (loss) income $ (5,021,400) $ 2,704,600 $ (7,492,200) $ 5,053,800
Basic (loss) earnings per share $ (0.59) $ 0.32 $ (0.88) $ 0.60
Diluted (loss) earnings per share $ (0.59) $ 0.32 $ (0.88) $ 0.59
Basic weighted-average common shares outstanding (in shares) 8,541,020 8,446,671 8,517,838 8,429,086
Effect of dilutive options and other equity instruments (in shares)   32,583   130,982
Diluted weighted-average common shares outstanding (in shares) 8,541,020 8,479,254 8,517,838 8,560,068
Cash dividends declared per common share (in dollars per share) $ 0.20 $ 0.20 $ 0.60 $ 0.60